when it came to light it had to be announced. It firms up the fundamentals and now puts phase 1 results in light over coming 3 weeks. If it wasn’t from the market conditions it would have doubled. Company still worth 100 million like its peers on phase 1 stages. This 18 million market cap not one biotech with this potential trades at this valuation with a unmet 60 billion dollar indication
- Forums
- ASX - By Stock
- NYR
- Ann: Significant Neuroprotection in Traumatic Brain Injury Study
NYR
nyrada inc.
Add to My Watchlist
10.0%
!
22.5¢

Ann: Significant Neuroprotection in Traumatic Brain Injury Study, page-9
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
-0.025(10.0%) |
Mkt cap ! $47.45M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 22.5¢ | $209.3K | 892.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7150 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 416666 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 157420 | 0.220 |
2 | 120005 | 0.215 |
4 | 170000 | 0.210 |
1 | 30000 | 0.205 |
3 | 119346 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 416666 | 1 |
0.245 | 5000 | 1 |
0.250 | 38461 | 1 |
0.255 | 25000 | 1 |
0.260 | 54498 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online